SE384856B - Sett att framstella indolderivat med anti-inflammatorisk, analgetisk och antipyretisk verkan - Google Patents
Sett att framstella indolderivat med anti-inflammatorisk, analgetisk och antipyretisk verkanInfo
- Publication number
- SE384856B SE384856B SE7214215A SE1421572A SE384856B SE 384856 B SE384856 B SE 384856B SE 7214215 A SE7214215 A SE 7214215A SE 1421572 A SE1421572 A SE 1421572A SE 384856 B SE384856 B SE 384856B
- Authority
- SE
- Sweden
- Prior art keywords
- analgetic
- inflammatory
- way
- antipyretic effects
- preparing content
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1811672A GB1356834A (en) | 1971-11-03 | 1971-11-03 | Indole derivatives |
| GB1811672 | 1972-04-19 | ||
| GB3076772 | 1972-06-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE384856B true SE384856B (sv) | 1976-05-24 |
Family
ID=27257588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7214215A SE384856B (sv) | 1971-11-03 | 1972-11-02 | Sett att framstella indolderivat med anti-inflammatorisk, analgetisk och antipyretisk verkan |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US3884919A (OSRAM) |
| JP (1) | JPS4856667A (OSRAM) |
| AR (3) | AR198064A1 (OSRAM) |
| BE (1) | BE790679A (OSRAM) |
| CA (1) | CA983932A (OSRAM) |
| CH (1) | CH577499A5 (OSRAM) |
| DD (1) | DD105611A5 (OSRAM) |
| DE (1) | DE2253927A1 (OSRAM) |
| EG (1) | EG11358A (OSRAM) |
| ES (2) | ES408226A1 (OSRAM) |
| FR (1) | FR2158464B1 (OSRAM) |
| GB (1) | GB1356834A (OSRAM) |
| HU (1) | HU169711B (OSRAM) |
| IE (1) | IE37998B1 (OSRAM) |
| IL (1) | IL40521A (OSRAM) |
| NL (1) | NL7214807A (OSRAM) |
| SE (1) | SE384856B (OSRAM) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4022780A (en) * | 1973-03-06 | 1977-05-10 | Imperial Chemical Industries Limited | Process for the manufacture of indole derivatives |
| FR2421900A1 (fr) * | 1977-03-17 | 1979-11-02 | Sauba Lab | Piperazino-3-indoles, leur procede de preparation et leurs applications therapeutiques |
| US4316847A (en) * | 1979-07-30 | 1982-02-23 | Hoffmann-La Roche Inc. | Pyrroles and pyrrolidines |
| US4459227A (en) * | 1981-03-02 | 1984-07-10 | Duke University | Para-hydroxyphenylhydrazines as in situ precursors of iminoquinones and quinones |
| EP0746554A1 (en) * | 1994-02-23 | 1996-12-11 | Pfizer Inc. | 4-heterocyclyl-substituted quinazoline derivatives, processes for their preparation and their use as anti-cancer agents |
| US6252084B1 (en) * | 1994-03-15 | 2001-06-26 | Eli Lilly And Company | 1H-indole-3-acetamide sPLA2 inhibitors |
| JP2002504541A (ja) * | 1998-02-25 | 2002-02-12 | ジェネティックス・インスチチュート・インコーポレーテッド | ホスホリパーゼ酵素阻害剤 |
| US6500853B1 (en) | 1998-02-28 | 2002-12-31 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
| SE0200411D0 (sv) * | 2002-02-05 | 2002-02-05 | Astrazeneca Ab | Novel use |
| SE0200356D0 (sv) * | 2002-02-05 | 2002-02-05 | Astrazeneca Ab | Novel use |
| SE0201635D0 (sv) * | 2002-05-30 | 2002-05-30 | Astrazeneca Ab | Novel compounds |
| TW200307542A (en) * | 2002-05-30 | 2003-12-16 | Astrazeneca Ab | Novel compounds |
| SE0202241D0 (sv) | 2002-07-17 | 2002-07-17 | Astrazeneca Ab | Novel Compounds |
| SE0301010D0 (sv) * | 2003-04-07 | 2003-04-07 | Astrazeneca Ab | Novel compounds |
| SE0301009D0 (sv) * | 2003-04-07 | 2003-04-07 | Astrazeneca Ab | Novel compounds |
| ATE316077T1 (de) | 2003-04-25 | 2006-02-15 | Actimis Pharmaceuticals Inc | Pyrimidin-essigsäure derivate geeignet zur behandlung von crth2-bedingten krankheiten |
| EP1618094B1 (en) * | 2003-04-30 | 2007-09-05 | The Institutes for Pharmaceutical Discovery, LLC | Substituted heteroaryls as inhibitors of protein tyrosine phosphatases |
| SE0301569D0 (sv) | 2003-05-27 | 2003-05-27 | Astrazeneca Ab | Novel compounds |
| SE0302232D0 (sv) | 2003-08-18 | 2003-08-18 | Astrazeneca Ab | Novel Compounds |
| SA04250253B1 (ar) | 2003-08-21 | 2009-11-10 | استرازينيكا ايه بي | احماض فينوكسي اسيتيك مستبدلة باعتبارها مركبات صيدلانية لعلاج الامراض التنفسية مثل الربو ومرض الانسداد الرئوي المزمن |
| GB0324763D0 (en) | 2003-10-23 | 2003-11-26 | Oxagen Ltd | Use of compounds in therapy |
| SE0303180D0 (sv) | 2003-11-26 | 2003-11-26 | Astrazeneca Ab | Novel compounds |
| EP1718649B1 (en) | 2004-01-31 | 2009-06-10 | Actimis Pharmaceuticals, Inc., | Imidazo 1,2-c pyrimidinylacetic acid derivatives |
| GB0415320D0 (en) | 2004-07-08 | 2004-08-11 | Astrazeneca Ab | Novel compounds |
| GB0418830D0 (en) | 2004-08-24 | 2004-09-22 | Astrazeneca Ab | Novel compounds |
| ATE517085T1 (de) | 2004-11-23 | 2011-08-15 | Astrazeneca Ab | Zur behandlung von atemwegserkrankungen geeignete phenoxyessigsäurederivate |
| GB0500604D0 (en) | 2005-01-13 | 2005-02-16 | Astrazeneca Ab | Novel process |
| US8148572B2 (en) | 2005-10-06 | 2012-04-03 | Astrazeneca Ab | Compounds |
| TW200745003A (en) | 2005-10-06 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
| US7741360B2 (en) | 2006-05-26 | 2010-06-22 | Astrazeneca Ab | Bi-aryl or aryl-heteroaryl substituted indoles |
| EP2046740B1 (en) | 2006-07-22 | 2012-05-23 | Oxagen Limited | Compounds having crth2 antagonist activity |
| UA100983C2 (ru) | 2007-07-05 | 2013-02-25 | Астразенека Аб | Бифенилоксипропановая кислота как модулятор crth2 и интермедиаты |
| AU2008305633B2 (en) | 2007-09-25 | 2013-09-12 | Actimis Pharmaceuticals, Inc. | 2-S-benzyl substituted pyrimidines as CRTH2 antagonists |
| ATE547407T1 (de) | 2007-09-25 | 2012-03-15 | Actimis Pharmaceuticals Inc | Alkylthiopyrimidine als crth2-antagonisten |
| US7750027B2 (en) | 2008-01-18 | 2010-07-06 | Oxagen Limited | Compounds having CRTH2 antagonist activity |
| NZ587251A (en) | 2008-01-18 | 2011-12-22 | Oxagen Ltd | Indole derivatives having CRTH2 antagonist activity |
| EP2240444A1 (en) | 2008-01-22 | 2010-10-20 | Oxagen Limited | Compounds having crth2 antagonist activity |
| WO2009093026A1 (en) | 2008-01-22 | 2009-07-30 | Oxagen Limited | Compounds having crth2 antagonist activity |
| GB201322273D0 (en) | 2013-12-17 | 2014-01-29 | Atopix Therapeutics Ltd | Process |
| GB201407807D0 (en) | 2014-05-02 | 2014-06-18 | Atopix Therapeutics Ltd | Polymorphic form |
| GB201407820D0 (en) | 2014-05-02 | 2014-06-18 | Atopix Therapeutics Ltd | Polymorphic form |
| AU2019362753A1 (en) * | 2018-10-05 | 2021-05-20 | Vertex Pharmaceuticals Incorporated | Modulators of alpha-1 antitrypsin |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL125443C (OSRAM) * | 1963-06-06 | |||
| US3679692A (en) * | 1969-10-01 | 1972-07-25 | Mead Johnson & Co | Iminomethylindolines |
-
0
- BE BE790679D patent/BE790679A/xx unknown
-
1971
- 1971-11-03 GB GB1811672A patent/GB1356834A/en not_active Expired
-
1972
- 1972-09-28 IE IE1320/72A patent/IE37998B1/xx unknown
- 1972-09-29 CA CA152,944A patent/CA983932A/en not_active Expired
- 1972-10-06 IL IL40521A patent/IL40521A/xx unknown
- 1972-10-10 US US296202A patent/US3884919A/en not_active Expired - Lifetime
- 1972-10-27 AR AR244863A patent/AR198064A1/es active
- 1972-10-29 EG EG446/72A patent/EG11358A/xx active
- 1972-11-02 CH CH1597672A patent/CH577499A5/xx not_active IP Right Cessation
- 1972-11-02 SE SE7214215A patent/SE384856B/xx unknown
- 1972-11-02 NL NL7214807A patent/NL7214807A/xx unknown
- 1972-11-02 DD DD166646A patent/DD105611A5/xx unknown
- 1972-11-02 FR FR7238836A patent/FR2158464B1/fr not_active Expired
- 1972-11-02 JP JP47110172A patent/JPS4856667A/ja active Pending
- 1972-11-03 DE DE2253927A patent/DE2253927A1/de active Pending
- 1972-11-03 HU HUIE540A patent/HU169711B/hu unknown
- 1972-11-03 ES ES408226A patent/ES408226A1/es not_active Expired
-
1973
- 1973-07-31 AR AR249382A patent/AR203627A1/es active
- 1973-07-31 AR AR249381A patent/AR203626A1/es active
-
1975
- 1975-04-30 ES ES437331A patent/ES437311A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AR203627A1 (es) | 1975-09-30 |
| BE790679A (fr) | 1973-04-27 |
| IE37998B1 (en) | 1977-12-07 |
| IL40521A0 (en) | 1972-12-29 |
| NL7214807A (OSRAM) | 1973-05-07 |
| DD105611A5 (OSRAM) | 1974-05-05 |
| CH577499A5 (OSRAM) | 1976-07-15 |
| EG11358A (en) | 1977-02-28 |
| IE37998L (en) | 1973-05-03 |
| DE2253927A1 (de) | 1973-05-10 |
| JPS4856667A (OSRAM) | 1973-08-09 |
| GB1356834A (en) | 1974-06-19 |
| CA983932A (en) | 1976-02-17 |
| AR198064A1 (es) | 1974-05-31 |
| ES408226A1 (es) | 1976-02-01 |
| AR203626A1 (es) | 1975-09-30 |
| IL40521A (en) | 1975-06-25 |
| HU169711B (OSRAM) | 1977-02-28 |
| US3884919A (en) | 1975-05-20 |
| ES437311A1 (es) | 1977-04-01 |
| FR2158464B1 (OSRAM) | 1976-07-02 |
| FR2158464A1 (OSRAM) | 1973-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE384856B (sv) | Sett att framstella indolderivat med anti-inflammatorisk, analgetisk och antipyretisk verkan | |
| FI55379C (fi) | Polyolefinmassa med baettre vattenavledningsegenskaper foer framstaellning av papper och massans framstaellningsfoerfarande | |
| SE7602339L (sv) | Kinolonderivat och sett att framstella desamma | |
| SE398877B (sv) | Forfarande for framstellning av 14-hydroxi-morfinanderivat | |
| SE402283B (sv) | Karbazoler med antiinflammatorisk, analgetisk och antireumatisk verkan | |
| SE7605925L (sv) | Nya prostanderivat och sett att framstella desamma | |
| SE405599B (sv) | Forfarande for framstellning av pyridazinoner med terapeutisk verkan | |
| SE7508544L (sv) | Bensimidazol-derivat och sett att framstella desamma. | |
| BE786155A (fr) | Derives heterocycliques n-substitues ainsi que leur preparation | |
| SE397523B (sv) | Forfarande att framstella n-fenylpyrrolderivat med antiinflammatorisk och analgetisk verkan | |
| FI54592C (fi) | Foerpackning av straengar av med adhesionsmedel belagda glasfibrer och foerfarande foer framstaellning av foerpackningen | |
| FI56100B (fi) | Loesningskoncentrat med fungicid och acaricid verkan | |
| SE395892B (sv) | Forfarande for framstellning av piperidyl-bensimidazoliner med terapeutisk verkan | |
| SE392615B (sv) | Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat | |
| SE384686B (sv) | Forfarande for framstellning av linkomycinderivat | |
| SE399069B (sv) | Analogiforfarande for framstellning av triazolo-pyridino-isokinolin-derivat | |
| SE385896B (sv) | Forfarande for framstellning av 2,3-dihydro-4h-tieno-(3,2-c)(1)bensopyran-4-oner med analgetisk och antipyretisk verkan | |
| SE393982B (sv) | Sett att framstella dihydrokinolinderivat med antioxiderande verkan | |
| FI53790C (fi) | Foerfarande och anordning foer styrd gjutning av en form med smaelt metall | |
| SE401829B (sv) | Forfarande for framstellning av 5-fenyl-6,7-bensomorfanderivat och salter derav | |
| SE394680B (sv) | Forfarande for framstellning av cykliska fosfamidderivat | |
| SE409866B (sv) | Forfarande for framstellning av adenosinderivat | |
| IT956656B (it) | Composti disazoici loro preparazio ne e loro impiego | |
| SE390509B (sv) | Forfarande for framstellning av skivor av trematerial | |
| SE385897B (sv) | Forfarande for framstellning av bensoditianpyronderivat med terapeutisk verkan |